Моксонидин: опыт клинического применения у пациентов с артериальной гипертензией на фоне метаболического синдрома
Светлана Игоревна Ксенева, Бородулина Елена Валентиновна, Семиглазова Татьяна Александровна et al. · Сибирский научный медицинский журнал · 2009
24 week monitoring efficiency hypotensive therapies with Moxonidini of 18 patients with a metabolic syndrome has been carried out. Its metabolic neutrality has been shown. Against a background of the marked sympatholytic effects of the preparation the Eluding of its therapeutic effect has been revealed after 12 weeks of therapy, that defines the necessity of dynamic supervision after this category of patients for the correction of a doze of the preparation.
Cited by 0 works.